Business ❯ Pharmaceuticals

Market Trends

Revenue Growth Weight Loss Drugs US Market Pricing Strategies Drug Development Drug Supply Shortages Prescription Drugs Cost of Treatments Weight Loss Medications Drug Pricing Reshoring Generic Drugs Chronic Therapy Domestic Market Acquisition Strategies China Consumer Demand Acquisitions Consumer Health Products Drug Pipeline Company Acquisitions Stock Listings Sales Forecasts Drug Patents Dietary Supplements Retail Pharmacy Growth Cycles Stock Performance Vaccine Sales Biomanufacturing Competitor Analysis M&A Activity Product Launches Vertical Integration Patent Expirations Investment Strategies Biologics Patent Expiration Sales Growth Competition Growth Projections Growth Strategies Telehealth

FDA Faces Choice on Allowing Six Experimental Peptides for Compounding

A federal decision could shift many users from unregulated overseas suppliers to licensed pharmacies and force a plan for coordinated research and safety oversight

CVS Caremark Reverses Exclusion and Adds Lilly’s Foundayo and Zepbound to Its Formulary

AbbVie Tops Q1 and Raises 2026 Outlook as Skyrizi and Rinvoq Offset Humira Decline

West Pharmaceutical Raises 2026 Guidance After Double-Digit Q1 Growth

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

Telix Confirms Webcast Investor Sessions at Oppenheimer and TD Cowen Conferences

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Novartis Posts Q3 Sales Rise but Misses Views, Reaffirms 2025 Outlook

Pfizer Strikes U.S. Drug-Pricing Pact, Wins Exemption From 100% Import Tariff